Use tab to navigate through the menu items.
CANDO (Controlling Abnormal Network Dynamics using Optogenetics) is a world-class, multi-site, cross-disciplinary project to develop a cortical implant for optogenetic neural control. The goal is to create a first-in-human trial in patients with focal epilepsy. This seven year, £10M Innovative Engineering for Health Award, funded by the
Engineering and Physical Sciences Research Council (EPSRC)
involves a team of over 30 neuroscientists, engineers and clinicians based at
Imperial College London
University College London
The Newcastle Hospitals NHS Foundation Trust
More about the project: